地中海贫血是一种遗传性溶血性贫血。由于遗传物质(基因)的缺陷,引起血红蛋白肽链合成障碍。根据肽链合成障碍的不同,地中海贫血主要分为α型与β型两大类型,其中以β地中海贫血较为常见。目前,多数人认为本病尚无根治方法,对脾切除意见尚不一致。对脾切除后远期疗效观察的资料也较少,我们在已往观察的基础上,最近又对地中海贫血脾切除后4～16年的18例进行了追踪观察,现对其远期疗效报导如下。 Thalassemia is a hereditary hemolytic anemia. Due to the genetic material (gene) defects, causing hemoglobin peptide synthesis barriers. According to the different barriers of peptide synthesis, thalassemia is mainly divided into two types of α and β types, of which β thalassemia is more common. At present, most people think there is no cure for this disease, and opinions about splenectomy are not the same. On the long-term efficacy of splenectomy after the observation of the information is less, we have observed in the past, based on the recent spleen resection of thalassemia 4 to 16 years after the 18 cases were followed up, now its long-term efficacy reported as follows .